Acidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysis

References

• Hollinger J, Wong MEK. The integrated processes of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 594–606
   PubMed Web of Science ®Google Scholar
• Dallari D, Fini M, Stagni C, Torricelli P, Aldini NN, Giavaresi G, Cenni E, Baldini N, Cenacchi A, Bassi A, et al. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 2006; 24: 877–888
   PubMed Web of Science ®Google Scholar
• Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004; 15: 29–35
   PubMed Web of Science ®Google Scholar
• Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995; 13: 655–663
   PubMed Web of Science ®Google Scholar
• Vogel JP, Szalay K, Geiger F, Kramer M, Richter W, Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 2006; 17: 462–469
   PubMed Web of Science ®Google Scholar
• Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br 2009; 91: 987–996
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638–646
   PubMed Web of Science ®Google Scholar
• Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992; 15: 1598–1604
   PubMed Web of Science ®Google Scholar
• Liu Y, Kalén A, Risto O, Wahlström O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen 2002; 10: 336–340
   PubMed Web of Science ®Google Scholar
• Wahlström O, Linder C, Kalén A, Magnusson P. Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells. Platelets 2007; 18: 113–118
   PubMed Web of Science ®Google Scholar
• Dayan F, Mazure NM, Brahimi-Horn MC, Pouysségur J. A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment. Cancer Microenviron 2008; 1: 53–68
   PubMedGoogle Scholar
• Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 2004; 35: 1316–1322
   PubMed Web of Science ®Google Scholar
• Kalén A, Wahlström O, Halling Linder C, Magnusson P. The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors. Biochem Biophys Res Commun 2008; 375: 261–264
   PubMedGoogle Scholar
• Wahlström O, Linder C, Kalén A, Magnusson P. Acidic preparations of platelet concentrates release bone morphogenetic protein-2. Acta Orthop 2008; 79: 433–437
   PubMed Web of Science ®Google Scholar
• Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V, Canalis E. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 2003; 144: 1972–1978
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, Tabin CJ. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006; 2: 2116–2130
   Google Scholar
• Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest 2008; 118: 421–428
   PubMed Web of Science ®Google Scholar
• Krause C, de Gorter DJJ, Karperien M, ten Dijke P. Signal transduction cascades controlling osteoblast differentiation. Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th, CJ Rosen. American Society for Bone and Mineral Research, Washington, D.C.USA 2008; 10–16
   Google Scholar
• Rundle CH, Wang H, Yu H, Chadwick RB, Davis EI, Wergedal JE, Lau K-HW, Mohan S, Ryaby JT, Baylink DJ. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 2006; 38: 521–529
   PubMedGoogle Scholar
• Harris SA, Enger RJ, Riggs BL, Spelsberg TC. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995; 10: 178–186
   PubMed Web of Science ®Google Scholar
• Leutenegger CM, Mislin CN, Sigrist B, Ehrengruber MU, Hofmann-Lehmann R, Lutz H. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol 1999; 71: 291–305
   PubMed Web of Science ®Google Scholar
• Computational Biology Center at Memorial Sloan-Kettering Cancer Center [internet]. New York, NY, USA. Available from: http://cancer.cellmap.org/cellmap
   Google Scholar
• Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nature Med 1995; 1: 932–937
   PubMed Web of Science ®Google Scholar
• Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer 2008; 8: 967–975
   PubMed Web of Science ®Google Scholar
• Franovic A, Holterman CE, Payette J, Lee S. Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci USA 2009; 106: 21306–21311
   PubMedGoogle Scholar
• Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68: 8164–8172
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215–233
   PubMed Web of Science ®Google Scholar
• Bueno MJ, de Castro IP, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008; 7: 3143–3148
   PubMed Web of Science ®Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128–2136
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008; 27: 4373–4379
   PubMed Web of Science ®Google Scholar